[1]潘亮亮,张思涵,王雪晴,等.血管紧张素Ⅱ微量泵植入和皮下注射致小鼠心肌纤维化的造模方法比较[J].陕西医学杂志,2025,54(1):14-20.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.003]
　PAN Liangliang,ZHANG Sihan,WANG Xueqing,et al.Comparison of two modeling methods In mice myocardial fibrosis model induced by micropump and subcutaneous injection of Ang Ⅱ[J].,2025,54(1):14-20.[doi:DOI:10.3969/j.issn.1000-7377.2025.01.003]
点击复制

血管紧张素Ⅱ微量泵植入和皮下注射致小鼠心肌纤维化的造模方法比较
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年1期
页码:
14-20
栏目:
基础研究
出版日期:
2025-01-05

文章信息/Info

Title:
Comparison of two modeling methods In mice myocardial fibrosis model induced by micropump and subcutaneous injection of Ang Ⅱ
作者:
潘亮亮1; 张思涵2; 王雪晴1; 杨晓薇1; 王少兰1; 李 汨1; 马晓真1; 于远望1
(1.陕西中医药大学基础医学院,陕西 咸阳 712046; 2.西藏民族大学医学院,陕西 咸阳 712082)
Author(s):
PAN Liangliang; ZHANG Sihan; WANG Xueqing; YANG Xiaowei; WANG Shaolan; LI Mi; MA Xiaozhen; YU Yuanwang
( Shaanxi University of Chinese Medicine,Xianyang 712046,China )
关键词:
血管紧张素Ⅱ;  心肌纤维化;  造模方法;  微量泵植入;  皮下注射;  动物模型
Keywords:
Ang Ⅱ;  myocardial fibrosis;  Modeling method;  Micropump subcutaneous implantation;  Subcutaneous injection;  Animal model
分类号:
R 542.2
DOI:
DOI:10.3969/j.issn.1000-7377.2025.01.003
文献标志码:
A
摘要:
目的:比较血管紧张素Ⅱ(Ang Ⅱ)微量泵植入和皮下注射两种造模方式及不同剂量致小鼠心肌纤维化的成模情况及成模差异性,确定较优的动物模型复制方法。方法:40只雄性C57BL/6小鼠随机分为空白对照组、微量泵组[微量泵皮下植入1.5 mg/(kg·d)]、皮下组1[皮下注射1.5 mg/(kg·d)]和皮下组2[皮下注射2.5 mg/(kg·d)],每组10只,空白组不做任何处理,其余组给予Ang Ⅱ,持续28 d,观察小鼠一般状态。第28天行心电图和超声心动图检测心功能,HE、Masson染色观察心脏病理变化,ELISA检测血清脑钠肽(BNP)水平,Western blot 检测心肌α-平滑肌肌动蛋白(α-SMA)、 Ⅰ 型胶原蛋白(Collagen Ⅰ)、Ⅲ 型胶原蛋白(Collagen Ⅲ)蛋白表达。结果:同空白对照组比较,各给药组小鼠一般状态、心电图受影响程度为微量泵组>皮下组2>皮下组1。超声心动图微量泵组和皮下组2的左室射血分数(EF)、左室短轴缩短率(FS)下降(均P<0.05),左 室 舒 张 末 期 内径(LVIDd)、左室收缩末期内径(LVIDs)、左室舒张末期容量(LVEDV)、左室收缩末期容量(LVESV)、左室质量(LVd Mass)均上升(均P<0.05); 皮下组1 的FS下降(P<0.05),LVIDs 、LVIDd上升(均 P<0.05),各组间EF比较有统计学差异(均P<0.05)。微量泵组和皮下组2的BNP均显著升高(P<0.05),皮下组1与空白对照组比较无统计学差异,各给药组间比较差异有统计学意义(P<0.05)。HE染色微量泵组炎性细胞浸润明显大于皮下组,Masson染色胶原纤维沉积高于皮下组2(均P<0.05),皮下组1与空白对照组比较无统计学差异(P>0.05)。Western blot微量泵组和皮下组2的 α-SMA、Collagen Ⅰ、Collagen Ⅲ蛋白表达显著增高(均P<0.05),皮下组1仅α-SMA增高(P<0.05)。结论:微量泵1.5 mg/(kg·d)和皮下注射2.5 mg/(kg·d)累积28 d均可建立心肌纤维化模型,微量泵组明显优于皮下注射; 皮下注射1.5 mg/(kg·d)诱导心肌纤维化不明显。
Abstract:
Objective:To compare the modelling methods of micropump implantation and subantaneous injection of Angiotensin Ⅱ(Ang Ⅱ),as well as the differences myocardial fibrosis induced by different doses in mice,and the optimal replication method of animal models was determined.Methods:Forty male C57BL/6 mice were randomly divided into blank control group,micropump group [micropump subcutaneous implantation of 1.5 mg/(kg·d)],subcutaneous group 1 [subcutaneous injection of 1.5 mg/(kg·d)] and subcutaneous group 2 [subcutaneous injection of 2.5 mg/(kg·d)],each group of 10,the blank group did not do any treatment,and the rest of the group was given Ang Ⅱ for 28 days,and the general state of the mice was observed.On the 28th day,electrocardiogram and echocardiography were performed to detect cardiac function,HE and Masson staining were used to observe the changes in cardiac theory,serum BNP levels were detected by ELISA,and myocardial α-SMA,Collagen Ⅰ,and Collagen Ⅲ.protein expressions were detected by Western blot.Results:Compared with the blank control group,the general state and electrocardiogram of mice in each administration group were the micropump group>the subcutaneous group>the subcutaneous group 1.The left ventricular ejection fraction(EF)and left ventricular short-axis shortening rate(FS)decreased in the echocardiographic micropump group and subcutaneousgroup 2(all P<0.01),and the left ventricular end-diastolic internal diameter(LVIDd),left ventricular end-systolic diameter(LVIDs),left ventricular end-diastolic volume(LVEDV),left ventricular end-systolic volume(LVESV),and left ventricular mass(LVd mass)increased(all P<0.05).In subcutaneous group 1,FS decreased(P<0.05),LVIDs and LVIDd increased(P<0.05),and EF was different among groups(P<0.01).The serum natriuretic peptide(BNP)in the micropump group and subcutaneous group 2 was significantly increased(P<0.05),and there was no significant difference between the subcutaneous group 1 and the blank control group,and the difference between the administration groups was statistically significant(P<0.05).The inflammatory cell infiltration in the HE stained micropump group was significantly higher than that in the subcutaneous group,and the collagen fibre deposition stained by Masson staining was higher than that in the subcutaneous group 2(P<0.05),and there was no difference between the subcutaneous group 1 and the blank control group(all P>0.05).The protein expressions of α-SMA,Collagen Ⅰand Collagen Ⅲ were significantly increased in Western blot micropump group and subcutaneous group 2(P<0.05),while only α-SMA was increased in subcutaneous group 1(P<0.05).Conclusion:Myocardial fibrosis models can be established by micropump at 1.5 mg/(kg·d)and subcutaneous injection at 2.5 mg/(kg·d)for 28 days,and the micropump group is significantly better than subcutaneous injection.Subcutaneous injection of 1.5 mg/(kg·d)induced myocardial fibrosis was not obvious.

参考文献/References:

[1] DISTLER J H W,GYORFI A H,Ramanujam M,et al.Shared and distinct mechanisms of fibrosis[J].Nat Rev Rheumatol,2019,15(12):705-730.
[2] 韩媛,曾新春.半乳糖凝集素-3抑制剂柑橘果胶对心力衰竭大鼠血浆N端B型利钠肽原及心肌纤维化的影响[J].陕西医学杂志,2022,51(6):680-683,705.
[3] ANGELI E,JORDAN M,OTTO M,et al.The role of fibrosis in cardiomyopathies:An opportunity to develop novel biomarkers of disease activity[J].Matrix Biol,2024,128:65-78.
[4] CHEN R,ZHANG H,TANG B,et al.Macrophages in cardiovascular diseases:Molecular mechanisms and therapeutic targets[J].Signal Transduct Target Ther,2024,9(1):130.
[5] ZHANG Z Z,WANG W,JIN H Y,et al.Apelin is a negative regulator of angiotensin II-mediated adverse myocardial remodeling and dysfunction[J].Hypertension,2017,70(6):1165-1175.
[6] PUGLIESE N R,MASI S,TADDEI S.The renin-angiotensin-aldosterone system:A crossroad from arterial hypertension to heart failure[J].Heart Fail Rev,2020,25(1):31-42.
[7] 俞婷,刘娜娜,钟青,等.沙库巴曲缬沙坦与传统血管紧张素转化酶抑制剂/血管紧张素受体拮抗剂治疗阵发性房颤疗效对比观察[J].陕西医学杂志,2023,52(10):1407-1410.
[8] 王琦,魏颖,朱烨,等.小鼠超声心动图成像方法学的探讨 [J].中国超声医学杂志,2014,30(12):1120-1123.
[9] BACMEISTER L,SCHWARZL M,WARNKE S,et al.Inflammation and fibrosis in murine models of heart failure[J].Basic Res Cardiol,2019,114(3):19.
[10] KIM J B,PORRECA G J,SONG L,et al.Polony multiplex analysis of gene expression(PMAGE)in mouse hypertrophic cardiomyopathy[J].Science,2007,316(5830):1481-1484.
[11] 彭琳茜,王瑞钰,李兴兵,等.TxNIP通过诱导氧化应激促进心肌纤维化的发生[J].中国病理生理杂志,2021,37(5):798-808.
[12] 肖雪,侯翠柳,王筱筱,等.NKT细胞通过下调PDGFR抑制Ang Ⅱ诱导的小鼠血管平滑肌细胞表型转换[J].中国病理生理杂志,2020,36(8):1345-1350.
[13] BACHMANN J C,BAUMGART S J,URYGA A K,et al.Fibrotic signaling in cardiac fibroblasts and vascular smooth muscle cells:The dual roles of fibrosis in HFpEF and CAD[J].Cells,2022,11(10):1657.
[14] MATSIUKEVICH D,KOVACS A,LI T,et al.Characterization of a robust mouse model of heart failure with preserved ejection fraction[J].Am J Physiol Heart Circ Physiol,2023,325(2):H203-H231.
[15] DHALLA N S,MOTA K O,ELIMBAN V,et al.Role of vasoactive hormone-induced signal transduction in cardiac hypertrophy and heart failure[J].Cells,2024,13(10):856.
[16] FRANGOGIANNIS N G.Cardiac fibrosis[J].Cardiovasc Res,2021,117,1450-1488.
[17] 杨俊,邬光敏,付品婷,等.胸主动脉夹层动物模型研究进展[J].中国普通外科杂志,2020,29(12):1503-1508.
[18] LI J C,JI A J,DONG L,et al.Angiotensin Ⅱ mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism[J].Mol Ther Nucleic Acids,2023,33:180-190.
[19] MA E,WU C,CHEN J,et al.Resveratrol prevents Ang Ⅱ-induced cardiac hypertrophy by inhibition of NF-κB signaling[J].Biomed Pharmacother,2023,165:115275.
[20] ZHANG Z,TANG J,SONG J,et al.Elabela alleviates ferroptosis,myocardial remodeling,fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6/STAT3/GPX4 signaling[J].Free Radic Biol Med,2022,181:130-142.
[21] KOPALIANI I,JARZEBSKA N,BILLOFF S,et al.Overexpression of dimethylarginine dimethylaminohydrolase 1 protects from angiotensin Ⅱ-induced cardiac hypertrophy and vascular remodeling[J].Am J Physiol Heart Circ Physiol,2021,321(5):h825-h838.
[22] 马定虎,周宗涛,李政,等.ZLY18通过抑制TGF-β1/Smads通路改善血管紧张素Ⅱ诱导的心肌纤维化[J].中国药理学通报,2023,39(2):229-238.
[23] ABID S,MUSTAFA ZAIDI S H,HUNDE M Z,et al.Usefulness of electrocardiography QT interval for prediction of left ventricular diastolic dysfunction:A cross-sectional study[J].Ann Med Surg(Lond),2023,85(6):2459-2463.
[24] MOSCUCCI F,SCIOMER S,MAFFEI S,et al.Sex differences in repolarization markers:Telemonitoring for chronic heart failure patients[J].J Clin Med,2023,12(14):4714.
[25] 周宏伟,罗秀英.新活素联合左西孟旦治疗急性心肌梗死合并心源性休克的临床疗效研究[J].保健医学研究与实践,2022,19(2):9-14.
[26] TEEKAKIRIKUL P,EMINAGA S,TOKA O,et al.Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires TGF-β[J].J Clin Invest,2010,120(10):3520-3529.
[27] CHAFFIN M,PAPANGELI I,SIMONSON B,et al.Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy[J].Nature,2022,608(7921):174-180.
[28] 赵倩茹,曹梦菲,孙侠,等.Yes相关蛋白在血管紧张素Ⅱ诱导的心肌纤维化中的作用及机制研究[J].中华老年心脑血管病杂志,2022,24(3):306-310.
[29] 周文慧,汪波,夏圣.ISO和AngⅡ诱导小鼠心脏纤维化模型的表型及机制比较[J].中国细胞生物学学报,2020,42(1):110-117.

相似文献/References:

[1]韩 媛,曾新春.半乳糖凝集素-3抑制剂柑橘果胶对心力衰竭大鼠血浆N端B型利钠肽原及心肌纤维化的影响[J].陕西医学杂志,2022,51(6):680.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.009]
　HAN Yuan,ZENG Xinchun.Effects of Galectin-3 inhibitor citrus pectin on NT-proBNP and myocardial fibrosis in heart failure rats[J].,2022,51(1):680.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.009]
[2]刘 鹏,陈 阵.微小RNA-19a-3p对充血性心力衰竭模型大鼠心肌纤维化的影响及机制研究[J].陕西医学杂志,2023,52(9):1125.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.003]
　LIU Peng,CHEN Zhen.Effect and mechanism of microRNA-19a-3p on myocardial fibrosis in rats with congestive heart failure[J].,2023,52(1):1125.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.003]
[3]谢继超,沈 冲,杨 松.血小板源性生长因子在心血管系统疾病中的作用研究进展[J].陕西医学杂志,2023,52(9):1279.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.039]
　XIE Jichao,SHEN Chong,YANG Song.Research progress of platelet-derived growth factor in cardiovascular diseases[J].,2023,52(1):1279.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.039]
[4]吴 宾,杨自更,王 杰,等.双特异性磷酸酶9对低氧性肺动脉高压小鼠心肺损伤的改善作用实验研究[J].陕西医学杂志,2024,(12):1593.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.002]
　WU Bin,YANG Zigeng,WANG Jie,et al.Improvement effects of dual specificity phosphatase 9 on cardiopulmonary injury in mice with hypoxic pulmonary hypertension[J].,2024,(1):1593.[doi:DOI:10.3969/j.issn.1000-7377.2024.12.002]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81904038); 陕西省教育厅重点科学研究计划项目(23JS009,22JS004); 陕西省中西医结合心血管病防治重点实验室项目(303-1730202030)
更新日期/Last Update: 2025-01-06